TL;DR
Over the past few years, many medical AI applications have focused on two major categories of tasks:
- Recognition and prediction: medical imaging, assisted diagnosis, risk scoring, and report interpretation.
- Generation and explanation: clinical note summarization, health Q&A, medical knowledge retrieval, and report explanation.
These tasks are useful, but chronic disease management, aging intervention, and longevity medicine require something more difficult:
How does an individual biological state change over time under the influence of lifestyle, drugs, nutrition, exercise, sleep, stress, and environmental exposure?
This is not just an NLP question-answering problem. It is not simply a single-point classification problem either.
It is closer to a dynamic system modeling problem.
That is why medical AI may need to move from report interpretation toward life trajectory reasoning.
In other words, we need a new framework: the medical world model.
This article discusses:
- Why report-reading medical AI is not enough.
- What a medical world model is.
- How
State-Action-Transition-Evidence-Feedbackcan describe biomedical reasoning. - How SteeraMed Core works as an early medical world model prototype.
- How the SEMO algorithm supports candidate intervention reasoning.
- Current limitations and engineering challenges for medical world models.
1. Why report-reading AI is not enough
Medical AI can already do many useful things:
- Read health checkup reports.
- Explain laboratory values.
- Summarize clinical notes.
- Answer health-related questions.
- Retrieve medical knowledge from literature.
- Support imaging interpretation and risk prediction.
These are valuable applications.
However, when we move into chronic disease management, aging intervention, and longevity medicine, the problem becomes more complex.
An individual may have many types of data at the same time:
- clinical biomarkers;
- DNA methylation data;
- transcriptomics, proteomics, metabolomics, and other multi-omics data;
- inflammation, immune, and metabolic markers;
- sleep, exercise, stress, and lifestyle records;
- symptoms and functional status;
- medication, nutrition, exercise, and psychological intervention records;
- retesting and follow-up feedback.
The hard question is not:
What does this biomarker mean?
The hard question is:
How are these signals connected?
Which changes are primary and which are secondary?
Which state deviations should be tracked over time?
Which actions may change the future state?
Which metrics should be used for feedback?
How should the next round of reasoning be updated after feedback?
This is not just an NLP task.
It is a state transition problem.
This is exactly the type of problem a medical world model is meant to address.
2. What is a medical world model?
In AI and reinforcement learning, a world model usually refers to an internal model of how the world changes.
A simplified expression is:
state_t + action_t -> state_t+1
In plain language:
current state + current action -> next state
If we translate this idea into medicine and life sciences, the problem becomes:
patient_state_t + intervention_action_t -> patient_state_t+1
But the human body is not a game environment.
Medical systems have several important differences:
- The human body is multi-scale: molecules, cells, tissues, organs, and behaviors all interact.
- Medical data is multi-modal: omics, clinical biomarkers, imaging, text, wearables, and follow-up records.
- Health trajectories are long-term: chronic disease progression, aging, and intervention responses may unfold over years.
- The state is partially observable: many important variables cannot be directly measured.
- Interventions have safety constraints: model reasoning must not be treated as clinical decision-making.
Therefore, a medical world model should not be understood as a universal predictor.
A more useful definition is:
A medical world model is a structured reasoning framework that represents biomedical state, candidate action, transition hypothesis, evidence chain, and feedback loop over time.
A medical world model does not merely ask:
Is this person high risk?
It asks:
What is the current state?
What are the candidate actions?
How may an action change the state?
What evidence supports the transition hypothesis?
What feedback should be observed?
How should the next round of reasoning be updated?
3. The core abstraction: State-Action-Transition-Evidence-Feedback
To make a medical world model more engineering-friendly, we can start with five core objects:
State -> current biological and clinical state
Action -> candidate intervention or management action
Transition -> state-change hypothesis
Evidence -> mechanism and literature evidence
Feedback -> retesting and follow-up observations
A simplified Python-style representation might look like this:
class MedicalWorldModel:
def __init__(self):
self.state = None # current patient state
self.actions = [] # candidate actions
self.transitions = [] # transition hypotheses
self.evidence = [] # evidence chains
self.feedback = [] # follow-up observations
A more detailed abstraction:
class State:
biomarkers: dict
omics_features: dict
clinical_features: dict
functional_features: dict
lifestyle_features: dict
class Action:
action_type: str
target_modules: list
mechanism_hypothesis: str
constraints: list
class Transition:
from_state: State
action: Action
expected_direction: dict
uncertainty: float
class Evidence:
source_type: str
source_url: str
mechanism: str
confidence_level: str
class Feedback:
followup_time: str
observed_changes: dict
adherence: str
adverse_events: list
This is not a clinical implementation.
It is a conceptual data structure showing one important principle:
A medical world model should not only generate a text recommendation. It should organize state, action, transition, evidence, and feedback into a traceable structure.
This is also the foundation of a steerable medical world model.
4. Medical world model vs. risk prediction model
Traditional medical AI often focuses on risk prediction.
A risk model usually asks:
What is the probability that this person will develop a disease?
or:
Is this person high-risk, medium-risk, or low-risk?
A medical world model asks a different set of questions:
If we take a certain action, how may the state change?
Why may the state change in that direction?
Which biomarkers or functional outcomes should be observed?
How should feedback update the next round of reasoning?
A simple comparison:
| Dimension | Risk prediction model | Medical world model |
|---|---|---|
| Core question | How high is the risk? | How may the state change? |
| Input | Current features | State, action, evidence, feedback |
| Output | Risk score or class | Transition hypothesis and observation plan |
| Time dimension | Often weak | Central |
| Feedback loop | Usually secondary | Core component |
For chronic disease management and aging intervention, the second approach is especially important.
Aging is not a single disease. Chronic disease is rarely a single pathway. Both are multi-system, long-term, and feedback-sensitive processes.
5. From a steerable world model framework to SteeraMed Core
Based on this idea, DeepOMe first proposed a steerable world model framework for biomedicine.
In the preprint World Models for Biomedicine: A Steerability Framework, we explored the following question:
Can biological state only be passively predicted, or can it be modeled around observable state, executable action, transition hypothesis, evidence chain, and feedback process in a steerable way?
Preprint DOI / URL:
https://doi.org/10.20944/preprints202605.0366.v1
Based on this framework, DeepOMe released another preprint on May 25, 2026:
SteeraMed: A Biomedical World Model for N-of-1 Intervention Reasoning Across Chronic Diseases and Aging
This preprint further implements the steerable biomedical world model idea into an early tool form for chronic disease and aging intervention scenarios: SteeraMed Core.
Preprint DOI / URL:
https://doi.org/10.20944/preprints202605.1578.v1
It is important to be clear about the boundary:
SteeraMed Core is not a clinical decision system. It is an early medical world model prototype for research, clinical collaboration, and health management tool exploration.
6. SteeraMed Core as a medical world model prototype
From an engineering point of view, SteeraMed Core can be understood as an early medical world model prototype.
Its goal is not to directly output a treatment plan.
Its goal is to structure the reasoning process.
A simplified pipeline:
Input:
Individual multi-dimensional data
- DNA methylation
- multi-omics features
- clinical biomarkers
- symptoms and functional status
- lifestyle records
Process:
1. Build state representation
2. Detect state deviation
3. Generate candidate actions
4. Build transition hypotheses
5. Link evidence chains
6. Design feedback metrics
Output:
Explainable, traceable, auditable intervention reasoning structure
A simplified pseudocode version:
def steeramed_core_pipeline(user_data):
state = build_state_representation(user_data)
deviations = detect_state_deviation(state)
candidate_actions = generate_candidate_actions(deviations)
transition_hypotheses = []
for action in candidate_actions:
evidence_chain = retrieve_evidence(state, action)
transition = infer_transition(state, action, evidence_chain)
feedback_plan = design_feedback_metrics(state, action, transition)
transition_hypotheses.append({
"state": state,
"action": action,
"evidence": evidence_chain,
"transition": transition,
"feedback": feedback_plan,
})
return transition_hypotheses
A real system would be much more complex.
It would involve:
- data cleaning;
- feature engineering;
- network modeling;
- evidence retrieval;
- uncertainty estimation;
- human-in-the-loop review;
- longitudinal feedback integration.
But the core idea is simple:
Do not just generate recommendations. Build a traceable reasoning structure.
That is what makes SteeraMed Core a medical world model prototype rather than a report generator.
7. SEMO: the network-remodeling layer behind SteeraMed
One important algorithmic foundation behind SteeraMed Core is the SEMO algorithm.
SEMO stands for:
Selective Remodeling of Protein Networks by Chemicals
It is a computational framework for selectively remodeling protein networks using chemicals.
The key question SEMO tries to address is:
In an individual biological network, where are the measurable state deviations? Which candidate compounds, nutrients, drugs, or lifestyle actions may push the state in a better direction through network remodeling?
From an algorithmic perspective, SEMO is not a simple recommender system.
A simple recommender system might look like this:
user features -> recommended supplement or lifestyle advice
SEMO emphasizes a different chain:
individual omics state
-> network deviation modules
-> candidate action networks
-> mechanism evidence
-> feedback metrics
In other words, SEMO focuses on:
- network deviation in individual omics signals;
- target networks associated with candidate actions;
- mechanism connections between state and intervention;
- feedback metrics that can track the intervention hypothesis.
The related method framework has been granted an invention patent.
The relationship between SEMO and SteeraMed Core can be summarized as:
SEMO provides the network-remodeling and candidate-intervention reasoning layer. SteeraMed Core places this capability inside a medical world model framework of State-Action-Transition-Evidence-Feedback.
8. Why medical world models matter for longevity AI
Longevity technology should not stop at “measuring an age.”
If a test cannot explain state deviation, organize candidate actions, design feedback metrics, and support the next round of calibration, it may easily become a one-time report product.
A meaningful AI longevity system may need at least four layers:
1. Data input layer
DNA methylation, multi-omics, clinical biomarkers,
wearable data, symptoms, lifestyle, follow-up records
2. State representation layer
organ systems, molecular pathways, functional states,
risk signals, aging hallmarks
3. Action reasoning layer
nutrition, exercise, drugs, psychology, sleep,
lifestyle and other candidate actions
4. Feedback calibration layer
retesting, follow-up, adherence, adverse events,
state update and next-round reasoning
From this perspective, a medical world model is not just an app.
It is not just a report generator.
It is a long-term infrastructure for organizing state, action, transition, evidence, and feedback.
9. Three early demo views
SteeraMed Core currently includes three early demo views to show how a medical world model may move from concept to prototype.
The descriptions below are intentionally brief. For detailed case definitions, data representations, evidence-chain construction, and prototype outputs, please refer to the SteeraMed preprint:
SteeraMed: A Biomedical World Model for N-of-1 Intervention Reasoning Across Chronic Diseases and Aging
DOI: 10.20944/preprints202605.1578.v1
9.1 Depression Patient View
Depression may involve sleep, stress, inflammation, metabolism, neuroendocrine state, life events, drug response, social support, and individual biological differences.
In the SteeraMed preprint, the Depression Patient View is used as one example of how a medical world model can organize patient-facing state signals, candidate actions, evidence chains, and follow-up feedback into a computable observation path. The technical details are described in the SteeraMed preprint above.
9.2 Anti-aging Patient View
In longevity medicine, individual differences are especially important.
In the SteeraMed preprint, the Anti-aging Patient View demonstrates how DNA methylation, Aging Hallmarks, organ-system signals, metabolic-immune status, and lifestyle factors can be integrated into a medical world model view to help identify candidate steerability factors and retesting metrics. The detailed implementation is described in the SteeraMed preprint above.
9.3 Rheumatoid Arthritis Scientist View
Rheumatoid arthritis is a chronic inflammatory and immune-related disease involving immune cells, inflammatory cytokines, joint tissue damage, drug response, and long-term disease activity.
In the SteeraMed preprint, the Rheumatoid Arthritis Scientist View is used to illustrate how a medical world model can organize disease state, immune-inflammatory modules, candidate targets, evidence chains, and feedback metrics into an auditable research structure. The detailed case description is provided in the SteeraMed preprint above.
10. Current limitations and engineering challenges
Medical world models are promising, but they must be treated carefully.
Several challenges remain:
- Data challenge: real-world data is often discontinuous, incomplete, and non-standardized.
- Validation challenge: model reasoning requires prospective observation and long-term follow-up.
- Causality challenge: correlation is not causation, and mechanism chains still need validation.
- Safety challenge: model outputs must not be treated as direct clinical decisions.
- Engineering challenge: multi-omics, clinical, text, and wearable data need unified modeling.
- Human-in-the-loop challenge: the system should support researchers and professionals, not replace professional judgment.
Therefore, SteeraMed Core is still an MVP tool.
It is mainly intended for research, clinical collaboration, and health management tool exploration. It is used to organize evidence, generate hypotheses, and track feedback.
It does not replace physicians, does not promise individual clinical outcomes, and should not be considered a validated medical device, diagnostic system, or treatment decision system.
11. Takeaway
If medical AI wants to truly enter chronic disease management and longevity medicine, it cannot remain limited to static report interpretation.
It needs to address a harder set of questions:
How does state change?
How does action influence state?
How does evidence constrain transition reasoning?
How does feedback calibrate the model?
That is the value of a medical world model.
SteeraMed Core is an early medical world model prototype developed by DeepOMe. It attempts to organize State-Action-Transition-Evidence-Feedback into an explainable, traceable, auditable, and iterative reasoning framework for chronic disease management, aging intervention, and N-of-1 reasoning.
About DeepOMe
DeepOMe starts from DNA methylation and aims to build AI world models of human aging, moving longevity technology from static testing toward dynamic reasoning.
DeepOMe uses DNA methylation and other epigenetic information as an entry point for representing life state, exploring molecular aging states, organ-system risk signals, and long-term health trajectory modeling.
In AI longevity technology, DeepOMe focuses on SEMO, SteeraMed Core, the DeepKang longevity medicine agent platform, and root-cause reasoning agents for individualized health management, resource integration, and long-term feedback loops.
Related links:
- DeepOMe: https://deepome.com
- Steerable World: https://steerable.world
- SteeraMed: https://SteeraMed.com
References
[1] Ha, D., & Schmidhuber, J. World Models. arXiv, 2018.
https://arxiv.org/abs/1803.10122
Conference version: Recurrent World Models Facilitate Policy Evolution. NeurIPS, 2018.
https://papers.nips.cc/paper/7512-recurrent-world-models-facilitate-policy-evolution
[2] LeCun, Y. A Path Towards Autonomous Machine Intelligence. OpenReview, 2022.
https://openreview.net/forum?id=BZ5a1r-kVsf
[3] Moor, M., Banerjee, O., Abad, Z. S. H., Krumholz, H. M., Leskovec, J., Topol, E. J., & Rajpurkar, P. Foundation models for generalist medical artificial intelligence. Nature, 2023, 616, 259–265.
https://doi.org/10.1038/s41586-023-05881-4
[4] Katsoulakis, E., Wang, Q., Wu, H., Shahriyari, L., Fletcher, R., Liu, J., Achenie, L., Liu, H. H., Jackson, P., Xiao, Y., Syeda-Mahmood, T., & Deng, J. Digital twins for health: a scoping review. npj Digital Medicine, 2024, 7, 77.
https://doi.org/10.1038/s41746-024-01073-0
[5] Xiong, J. World Models for Biomedicine: A Steerability Framework. Preprints.org, 2026.
https://doi.org/10.20944/preprints202605.0366.v1
[6] Xiong, J. SteeraMed: A Biomedical World Model for N-of-1 Intervention Reasoning Across Chronic Diseases and Aging. Preprints.org, 2026.
DOI: 10.20944/preprints202605.1578.v1
[7] Xiong, J. Utilizing Pre-trained Network Medicine Models for Generating Biomarkers, Targets, Re-purposing Drugs, and Personalized Therapeutic Regimes: COVID-19 Applications. bioRxiv, 2023.
